An Innovative Chemical Adherence Test Demonstrates Very High Rates of Nonadherence to Oral Cardio-Metabolic Medications

Kidney Int Rep. 2023 Sep 29;8(12):2818-2821. doi: 10.1016/j.ekir.2023.09.033. eCollection 2023 Dec.

Hanad Osman¹, Dan Lane^{2

3}, Dennis Bernieh^{4

5}, Samuel Seidu¹, Prashanth Patel², Kamlesh Khunti^{1

6}, Nigel J Brunskill^{4

7}, Gang Xu⁷, Pankaj Gupta^{2

3

4}

¹ Diabetes Research Centre, Department of Population Health Sciences, College of Life Sciences, University of Leicester, Leicester, UK.
² Department of Metabolic Medicine and Chemical Pathology University Hospitals of Leicester NHS Trust, Leicester, UK.
³ Leicester van Geest Multi-Omics Facility, Hodgkin Building, University of Leicester, Leicester, UK.
⁴ Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
⁵ National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Glenfield Hospital, Groby Road, Leicester, UK.
⁶ NIHR Applied Research Collaboration East Midlands, Leicester General Hospital, Leicester, UK.
⁷ John Walls Renal Unit, Leicester General Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK.

No abstract available

Keywords: cardio-metabolic disease; cardio-metabolic medications; chemical adherence testing; chronic kidney disease; nonadherence.